Fate Therapeutics Inc (FATE.O)

+ 收藏

资产负债表(Fate Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见36,056,000.0037,909,000.0036,917,000.00121,322,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见3,539,000.004,127,000.001,048,000.00858,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见9,302,000.009,244,000.0013,461,000.009,973,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见243,012,000.00259,014,000.00267,962,000.00262,222,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见291,909,000.00310,294,000.00319,388,000.00394,375,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见64,384,000.0082,392,000.0087,534,000.0092,116,000.00
 受限制存款及现金非流动(元) 会员可见会员可见会员可见会员可见10,227,000.0010,227,000.0015,177,000.0015,177,000.00
 长期投资(元) 会员可见会员可见会员可见会员可见27,657,000.0033,607,000.0047,162,000.007,595,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见46,517,000.0058,450,000.0059,556,000.0060,629,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见148,785,000.00184,676,000.00209,429,000.00175,517,000.00
总资产(元) 会员可见会员可见会员可见会员可见440,694,000.00494,970,000.00528,817,000.00569,892,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见7,416,000.006,893,000.006,644,000.006,402,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见9,365,000.006,349,000.005,495,000.006,765,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见21,348,000.0023,580,000.0022,654,000.0032,043,000.00
 递延收入流动(元) 会员可见会员可见-会员可见393,000.00600,000.00-159,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见-----
 流动负债合计(元) 会员可见会员可见会员可见会员可见38,522,000.0037,422,000.0034,793,000.0045,369,000.00
非流动负债:
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见77,849,000.0092,085,000.0093,918,000.0095,668,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见5,597,000.003,137,000.003,124,000.002,740,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见83,446,000.0095,222,000.0097,042,000.0098,408,000.00
总负债(元) 会员可见会员可见会员可见会员可见121,968,000.00132,644,000.00131,835,000.00143,777,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见114,000.00114,000.00114,000.00114,000.00
 优先股(元) 会员可见会员可见会员可见会员可见3,000.003,000.003,000.003,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见1,716,335,000.001,707,215,000.001,695,450,000.001,685,928,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-1,397,994,000.00-1,345,841,000.00-1,298,163,000.00-1,259,736,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见268,000.00835,000.00-422,000.00-194,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见318,726,000.00362,326,000.00396,982,000.00426,115,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见318,726,000.00362,326,000.00396,982,000.00426,115,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见440,694,000.00494,970,000.00528,817,000.00569,892,000.00
公告日期 2026-02-262025-11-132025-08-122025-05-132025-03-052024-11-122024-08-132024-05-09
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院